[go: up one dir, main page]

MX2009008165A - Metodo para disminuir la inflamacion y el esfuerzo oxidante en mamiferos. - Google Patents

Metodo para disminuir la inflamacion y el esfuerzo oxidante en mamiferos.

Info

Publication number
MX2009008165A
MX2009008165A MX2009008165A MX2009008165A MX2009008165A MX 2009008165 A MX2009008165 A MX 2009008165A MX 2009008165 A MX2009008165 A MX 2009008165A MX 2009008165 A MX2009008165 A MX 2009008165A MX 2009008165 A MX2009008165 A MX 2009008165A
Authority
MX
Mexico
Prior art keywords
oxidative stress
mammals
decreasing inflammation
mammal
glucose
Prior art date
Application number
MX2009008165A
Other languages
English (en)
Inventor
George Roth
Michael Griffin Hayek
Stefan Patrick Massimino
Gary Mitchell Davenport
Mark A Lane
Donald Ingram
Original Assignee
Iams Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Iams Company filed Critical Iams Company
Publication of MX2009008165A publication Critical patent/MX2009008165A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K10/00—Animal feeding-stuffs
    • A23K10/30—Animal feeding-stuffs from material of plant origin, e.g. roots, seeds or hay; from material of fungal origin, e.g. mushrooms
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/163—Sugars; Polysaccharides
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
    • A23K50/42—Dry feed
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
    • A23K50/48—Moist feed
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/12—Ophthalmic agents for cataracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Zoology (AREA)
  • Animal Husbandry (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Mycology (AREA)
  • Birds (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Botany (AREA)
  • Epidemiology (AREA)
  • Medical Informatics (AREA)
  • Ophthalmology & Optometry (AREA)
  • Neurology (AREA)
  • Nutrition Science (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Immunology (AREA)
  • Physiology (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Cardiology (AREA)

Abstract

La presente invención está dirigida a un método para disminuir la inflamación y el estrés en un mamífero, que comprende; la administración de una composición que comprende un antimetabolito de glucosa a un mamífero; y en donde dicha composición comprende cantidades suficientes de antimetabolito de glucosa para disminuir un nivel de proteína C reactiva en la sangre del mamífero después de la administración del antimetabolito de glucosa.
MX2009008165A 2007-02-01 2008-01-31 Metodo para disminuir la inflamacion y el esfuerzo oxidante en mamiferos. MX2009008165A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US89885407P 2007-02-01 2007-02-01
PCT/IB2008/050381 WO2008093302A2 (en) 2007-02-01 2008-01-31 Method for decreasing inflammation and oxidative stress in mammals

Publications (1)

Publication Number Publication Date
MX2009008165A true MX2009008165A (es) 2009-08-12

Family

ID=39674579

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2009008165A MX2009008165A (es) 2007-02-01 2008-01-31 Metodo para disminuir la inflamacion y el esfuerzo oxidante en mamiferos.

Country Status (11)

Country Link
US (1) US20080260696A1 (es)
EP (1) EP2124969A2 (es)
JP (1) JP2010516805A (es)
CN (1) CN102036670A (es)
AR (1) AR065146A1 (es)
AU (1) AU2008211599A1 (es)
BR (1) BRPI0808390A2 (es)
CA (1) CA2675510A1 (es)
MX (1) MX2009008165A (es)
RU (1) RU2429853C2 (es)
WO (1) WO2008093302A2 (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8563522B2 (en) * 1997-07-08 2013-10-22 The Iams Company Method of maintaining and/or attenuating a decline in quality of life
US8877178B2 (en) 2003-12-19 2014-11-04 The Iams Company Methods of use of probiotic bifidobacteria for companion animals
US20050158294A1 (en) 2003-12-19 2005-07-21 The Procter & Gamble Company Canine probiotic Bifidobacteria pseudolongum
US20090252834A1 (en) * 2004-05-10 2009-10-08 Michael Griffin Hayek Compositions comprising glucose anti-metabolites
WO2006130188A1 (en) 2005-05-31 2006-12-07 The Iams Company Feline probiotic bifidobacteria
DK1880001T3 (da) 2005-05-31 2011-09-12 Iams Company Feline probiotiske lactobacilli
CN101711158A (zh) 2007-02-01 2010-05-19 爱默思公司 使用葡萄糖抗代谢物、鳄梨或鳄梨提取物减轻哺乳动物炎症和应激反应的方法
US9771199B2 (en) 2008-07-07 2017-09-26 Mars, Incorporated Probiotic supplement, process for making, and packaging
US10104903B2 (en) 2009-07-31 2018-10-23 Mars, Incorporated Animal food and its appearance
US20120283197A1 (en) 2011-05-02 2012-11-08 Ashok Premchand Luhadiya Compositions Comprising a Glucose Anti-Metabolite, BHA, and/or BHT
EP2805721B1 (en) * 2013-05-23 2018-09-05 IAMS Europe B.V. Mimicking the metabolic effect of caloric restrictions by administration of glucose anti-metabolites to enhance positive response in a mammal
KR101757164B1 (ko) * 2015-11-24 2017-07-12 이화여자대학교 산학협력단 항산화 및 항염증 식품 소재의 중재 효과 예측 지표 대사체
JP2018039752A (ja) * 2016-09-07 2018-03-15 花王株式会社 Ｎｒｆ２活性化剤
US12295388B2 (en) 2018-11-08 2025-05-13 Dsm Ip Assets B.V. Methods of modulating gastrointestinal metabolites
MX2021005374A (es) 2018-11-08 2021-09-14 Dsm Ip Assets Bv Metodos para dar soporte a homeostasis gastrointestinal.
CN116209450B (zh) * 2020-08-18 2024-08-09 食品科学有限责任企业 聚合乳清蛋白包封的抗氧化化合物及其制备方法

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2641548A (en) * 1950-04-06 1953-06-09 Helen W Heinrich Method of preserving avocados
US3398001A (en) * 1963-04-26 1968-08-20 Air Reduction Process of preparing and packaging frozen avocados
US3677898A (en) * 1969-01-31 1972-07-18 Ajinomoto Kk Acid protease and method of preparing the same
US4647453A (en) * 1984-10-18 1987-03-03 Peritain, Ltd. Treatment for tissue degenerative inflammatory disease
JPS6297221A (ja) * 1985-10-22 1987-05-06 ウチヤ・サ−モスタツト株式会社 可変型温度調節器
US4808626A (en) * 1986-09-23 1989-02-28 Monell Chemical Senses Center Use of 2,5-anhydro-D-mannitol as a food intake modifier
US4814193A (en) * 1988-04-06 1989-03-21 General Foods Corporation Reduction of microbial population on surface of food materials
US5126153A (en) * 1988-05-13 1992-06-30 Basic American Foods, Inc. Compositions and methods for inhibiting browning of processed produce
US5344824A (en) * 1990-02-02 1994-09-06 Matsutani Chemical Industries Co., Ltd. Method for reducing insulin secretion
US5756529A (en) * 1995-09-29 1998-05-26 G.D. Searle & Co. Substituted pyrazolyl benzenesulfonamides for use in veterinary therapies
US5871794A (en) * 1996-08-07 1999-02-16 Brito; Jorge Issac Stabilized guacamole and method for making same
US20060116330A1 (en) * 1997-07-08 2006-06-01 The Iams Company Methods of mimicking the metabolic effects of caloric restriction by administration of mannoheptulose
US20020035071A1 (en) * 1997-07-08 2002-03-21 Josef Pitha Mimicking the metabolic effects of caloric restriction by administration of glucose antimetabolites
US5939117A (en) * 1997-08-11 1999-08-17 Mantrose-Haeuser Co., Inc. Methods for preserving fresh fruit and product thereof
DE19860375A1 (de) * 1998-12-28 2000-07-06 Aventis Res & Tech Gmbh & Co Alpha Amylase-resistente Stärke zur Herstellung von Nahrungs- und Arzneimittel
US6358555B1 (en) * 1999-03-31 2002-03-19 Hideyuki Takahashi Process for producing frozen avocados
US6737089B2 (en) * 1999-08-27 2004-05-18 Morinda, Inc. Morinda citrifolia (Noni) enhanced animal food product
CN1268351C (zh) * 2000-08-01 2006-08-09 奥力榨油化株式会社 糖类吸收抑制剂及其制备方法
US6586027B2 (en) * 2001-02-23 2003-07-01 T.F.H. Publications, Inc. Health chew toy
EP1372614A4 (en) * 2001-03-16 2007-10-31 Andrx Pharmaceuticals Llc SULPHONYL UREA FORMULATION WITH CONTROLLED RELEASE
EP1277412A1 (en) * 2001-07-17 2003-01-22 Societe Des Produits Nestle S.A. Pet food composition for regulating body weight and preventing obesity and related disorders in pets
US7666459B2 (en) * 2001-09-12 2010-02-23 The Procter & Gamble Company Pet food compositions
US6896914B2 (en) * 2001-10-26 2005-05-24 David I. Chapnick Method for normalizing insulin levels
US6733795B2 (en) * 2002-07-30 2004-05-11 Laboratoires Expanscience Method for producing an avocado leaf extract rich in furanic lipids
WO2004012752A2 (fr) * 2002-07-30 2004-02-12 Laboratoires Expanscience Procede d'obtention d'un extrait de feuilles d'avocatier riche en lipides furaniques
AU2004294986B2 (en) * 2003-11-26 2010-09-09 Hill's Pet Nutrition, Inc. Method to reduce stool odor of companion animals
FR2869541B1 (fr) * 2004-04-30 2007-12-28 Expanscience Sa Lab Utilisation d'une composition comprenant du d-mannoheptulose et/ou du perseitol dans le traitement et la prevention des maladies liees a une modification de l'immunite innee
FR2869543B1 (fr) * 2004-04-30 2006-07-28 Expanscience Laboratoires Sa Medicament comprenant un extrait peptidique d'avocat destine au traitement et la prevention des maladies liees a une deficience du systeme immunitaire
US20050249837A1 (en) * 2004-05-10 2005-11-10 The Procter & Gamble Company Processes for preparing plant matter extracts and pet food compositions
KR20070034591A (ko) * 2004-06-17 2007-03-28 위스콘신 얼럼나이 리서어치 화운데이션 발작 및 발작병을 치료하기 위한 화합물 및 방법
WO2006105407A1 (en) * 2005-03-31 2006-10-05 Board of Supervisors of Louisiana State Univesity and Agricultural and Mechanical College Medical uses of shilianhua

Also Published As

Publication number Publication date
WO2008093302A2 (en) 2008-08-07
WO2008093302A3 (en) 2008-12-11
CN102036670A (zh) 2011-04-27
US20080260696A1 (en) 2008-10-23
JP2010516805A (ja) 2010-05-20
AU2008211599A1 (en) 2008-08-07
BRPI0808390A2 (pt) 2014-07-08
CA2675510A1 (en) 2008-08-07
RU2429853C2 (ru) 2011-09-27
EP2124969A2 (en) 2009-12-02
RU2009127333A (ru) 2011-03-10
AR065146A1 (es) 2009-05-20

Similar Documents

Publication Publication Date Title
MX2009008165A (es) Metodo para disminuir la inflamacion y el esfuerzo oxidante en mamiferos.
MX2009008166A (es) Metodo para disminuir la inflamacion y estres en un mamifero usando antimetabolitos de glucosa, aguacate o extractos de aguacate.
PH12013501319A1 (en) Fatty acid acetylated salicylates and their uses
MX2010012961A (es) Imidazopiridina y analogos relacionados como moduladores de sirtuina.
SG196775A1 (en) Chromenone analogs as sirtuin modulators
WO2009134973A8 (en) Quinolines and related analogs as sirtuin modulators
WO2010062863A3 (en) Compositions containing satiogens and methods of use
CL2009000782A1 (es) Metodo que comprende un compuesto derivado de oximetilen-arilo sustituido, inhibidores de dpp-iv; y su uso en el tratamiento de la diabetes y disminucion de trigliceridos, entre otras enfermedades.
MX2010002734A (es) Derivados de 1-amino-alquilciclohexano para el tratamiento y prevencion de perdida auditiva.
WO2009047644A3 (en) Method of treating vitamin d insufficiency and deficiency
AR059089A1 (es) Administracion intraventricular de una enzima para enfermedades de almacenamiento lisosomal
UA104447C2 (uk) Тіазолопіридинові сполуки, що модулюють сиртуїн
MX2011006084A (es) Isoindolinona y analogos relacionados como moduladores de sirtuina.
WO2010042886A3 (en) Pyrones for the treatment of metabolic disorders
MX2010000266A (es) Un método para disminuir los síntomas del consumo de alcohol.
WO2008070859A3 (en) Treatment of skin conditions by dickkopf1 (dkk1)
BRPI0717458A8 (pt) Utilização cosmética por via oral e/ou parenteral da glicosamina e da associação da glicosamina e pelo menos um composto polifenol, processo cosmético, composição para administração oral, e, complemento alimentar ou alimento funcional
EP2328550A4 (en) MUCOADHERENT COMPOSITIONS AND THEIR USE
MX2012005126A (es) Composiciones y metodos para tratar condiciones dermatologicas.
MX355388B (es) Composiciones farmaceuticas y metodos terapeuticos que emplean una combinacion de un compuesto complejo de manganeso y una forma compleja no de manganeso del compuesto.
MXPA06012206A (es) Composicion farmaceutica ozonizada y metodos.
WO2005097187A3 (en) Methods of preventing uvb-induced skin damage
PE20120515A1 (es) Formulaciones de deferiprona
WO2008139313A8 (es) Solución anestésica transparente de propofolol, con baja irritación venosa
WO2006049657A3 (en) Insulin secretion by anthocyanins and anthocyanidins

Legal Events

Date Code Title Description
FA Abandonment or withdrawal